Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
GLOBETECH MEDIA

Activated Brown Fat Controls Obesity and Metabolic Disorders

By BiotechDaily International staff writers
Posted on 08 May 2013
Image: First author Dr. Aaron Cypess is an assistant professor of medicine at Harvard Medical School (Photo courtesy of Joslin Diabetes Center, Beth Deaconess Medical Center, Harvard University Medical School).
Image: First author Dr. Aaron Cypess is an assistant professor of medicine at Harvard Medical School (Photo courtesy of Joslin Diabetes Center, Beth Deaconess Medical Center, Harvard University Medical School).
Researchers speculate that the development of new drugs to activate human brown adipose tissue (BAT) could lead to safe treatments for obesity and metabolic disorders.

White adipose tissue (WAT) stores excess calories, while BAT consumes molecular fuel for thermogenesis (heat generation) using the tissue-specific enzyme UCP1(uncoupling protein 1).

Investigators at Harvard Medical School (Boston, MA, USA) delved into the genetic expression and protein activities found in BAT to determine its possible future role in the treatment of obesity. To this end, they isolated neck fat from adult human volunteers and compared its gene expression, differentiation capacity, basal oxygen consumption, and oxygen consumption rate (OCR), to different mouse adipose depots.

Among findings reported in the April 21, 2013, online edition of the journal Nature Medicine was that the OCR of the human BAT cells from the deep location in the neck next to the longus colli was nearly 50% of the rate found for mouse BAT cells. In contrast, the OCR of human WAT was only one-hundredth of the OCR found in the most active human BAT from the longus colli depot.

The investigators established a protocol for growth in culture of new functional BAT cells (adipocytes) by differentiating precursor cells (preadipocytes) derived from both superficial and deep human neck fat tissue. When stimulated, these cells expressed the same genes as naturally occurring brown fat cells. The use of brown fat cells produced in vitro will encourage development of drugs and other treatments that increase BAT activity for the correction of obesity and other metabolic disorders.

“BAT is most abundant in the deep locations of the neck, close to the sympathetic chain and the carotid arteries, where it likely helps to warm blood and raise body temperature,” said first author Dr. Aaron M. Cypess, assistant professor of medicine at Harvard Medical School. “Now that we know where brown fat is, we can easily collect more cells for further study.”

“Our research has significant practical applications. If we stimulate the growth of brown fat in people, it may burn their white fat and help them lose weight, which lessens insulin resistance and improves diabetes,” said Dr. Cypess.

Related Links:

Harvard Medical School



Channels

Drug Discovery

view channel
Image: Molecular model of the protein Saposin C (Photo courtesy of Wikimedia Commons).

Nanovesicles Kill Human Lung Cancer Cells in Culture and in a Mouse Xenograft Model

Nanovesicles assembled from the protein Saposin C (SapC) and the phospholipid dioleoylphosphatidylserine (DOPS) were shown to be potent inhibitors of lung cancer cells in culture and in a mouse xenograft model.... Read more

Biochemistry

view channel

Possible New Target Found for Treating Brain Inflammation

Scientists have identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited eurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that suppress this enzyme.... Read more

Lab Technologies

view channel
Image: The FLUOVIEW FVMPE-RS Gantry microscope (Photo courtesy of Olympus).

New Multiphoton Laser Scanning Microscope Configurations Expand Research Potential

Two new configurations of a state-of-the-art multiphoton laser scanning microscope extend the usefulness of the instrument for examining rapidly occurring biological events and for obtaining images from... Read more

Business

view channel

Roche Acquires Signature Diagnostics to Advance Translational Research

Roche (Basel, Switzerland) will advance translational research for next generation sequencing (NGS) diagnostics by leveraging the unique expertise of Signature Diagnostics AG (Potsdam, Germany) in biobanks and development of novel NGS diagnostic assays. Signature Diagnostics is a privately held translational oncology... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.